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Abstract: We present a technique for the label-free detection and recognition of cancer 
biomarkers using metal nanoislands intended to be integrated in a novel type of nanobiosensor. 
His-tagged (scFv)-F7N1N2 is the antibody fragment which is directly immobilized, by coor-
dinative bonds, onto ∼5 nm nickel islands, then deposited on the surface of a quartz crystal of 
a quartz crystal microbalance (QCM) to validate the technique. Biomarker GTPase RhoA was 
investigated because it has been found to be overexpressed in various tumors and because we 
have recently isolated and characterized a new conformational scFv which selectively recognizes 
the active form of RhoA. We implemented a surface chemistry involving an antibiofouling 
coating of polyethylene glycol silane (PEG-silane) (,2 nm thick) and Ni nanoislands to reach 
a label-free detection of the active antigen conformation of RhoA, at various concentrations. 
The methodology proposed here proves the viability of the concept by using Ni nanoislands 
as an anchoring surface layer enabling the detection of a specific conformation of a protein, 
identified as a potential cancer biomarker. Hence, this novel methodology can be transferred 
to a nanobiosensor to detect, at lower time consumption and with high sensitivity, specific 
biomolecules.
Keywords: nickel nanoislands, cancer biomarkers, quartz crystal microbalance, PEG-silane, 
RhoA protein, nanobiosensor
Nanomedicine is emerging as one of the most exciting and promising application of 
nanobiotechnologies, increasing diagnostic possibilities and enabling the implementa-
tion of a personalized medicine.1,2 Nanobiotechnologies are expected to give rise to 
applications in vivo and in vitro that will both increase reliability of early diagnosis 
and beat the disease while it is at its weakest development stage.3
Nanoislands are ultrafine particles of a few to several hundred atoms, exhibiting 
a huge surface to volume ratio, explaining their potential reactivity with the environ-
ment and so their usefulness for highly sensitive bimolecular detection. Moreover, 
when very small nanoislands are used, the chances for protein denaturation can be 
minimized.4 For in vivo biomedical applications, the use of nanoislands presenting 
superparamagnetic behavior at room temperature is preferred,5 such as nanoislands 
of nickel, cobalt, or iron. Nanoislands of ferromagnetic metals have been intensively 
studied, due to their interesting physical properties, and used as catalysts for high-
density magnetic recording media or for single electron devices.6,7 However, although 
these have been utilized in nanoelectronics or in vivo nano-objects applications, they 
have never been used for in vitro biodetection of cancer biomarkers. Ni nanoislands 
are especially interesting due to the possible stable attachment of proteins on their International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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surfaces. The purification method developed by Porath 
et al8 is currently used in the microbiological protocols; 
it consists of binding proteins onto immobilized metal 
ion affinity chromatography (IMAC). The purification is 
possible because of the affinity the proteins with exposed 
amino acid cysteine or histidine side chains have, for 
metals such as Ni2+, Co2+, Zn2+, Cu2+, and Mn2+, through 
coordinative bonds. The nitrogen in the imidazole core 
histidine of 6His-tagged proteins binds to Ni2+ cations, and 
the dissociation constant has been reported to be around 
10−13 M in the case of His Ni-NTA at pH 8.9 In this work, 
we investigate this principle by using a very thin layer of 
Ni exhibiting nanoislands, coupled with a surface chem-
istry for attaching His-tagged antibody fragments for the 
ligand-binding assays.
A biomarker is described as an entity which can reveal 
through its concentration measurement either a normal 
biologic (pathogenic) process or a pharmacologic response 
to a therapeutic intervention. Cancer biomarkers such as 
prostate-specific antigens (PSA) refer to molecules in which 
the level of expression is changed in the tumor or in the 
blood, urine, or other body fluid of cancer patients.10 Beyond 
early detection, the information provided by biomarkers 
helps in determining the status of the disease, hence improv-
ing control and prevention of cancer.11 Rho GTPases are 
molecular switches which control a wide variety of signal 
transduction pathways in all eukaryotic cells. The roles of 
Rho GTPases in cells have been identified12 as controlling 
the dynamics of microtubules and actin cytoskeleton and 
influencing cell polarity. Their activity is regulated by 
GDP/GTP cycling, functioning in many cellular pathways, 
controlling proliferation. Hence, they are involved in almost 
every stage of tumorigenesis.13 The expression of some Rho 
family members such as Rho A or Rho B has been found 
to be increased or decreased in some human cancers.14 
These reasons are why we were interested in Rho GTpases 
as potential cancer biomarkers. However, only the active 
GTP-bound Rho forms are able to activate the signaling 
pathway involved in tumorigenesis. This raises the issue 
of being able to detect specifically the active form of this 
biomarker. The challenge, related to the ability to sense 
the conformation of a protein with a nanobiosensor forms 
the core of this work. For achieving this purpose, we have 
recently identified a conformational-specific single chain 
fragment variable (scFv), using phage display techniques, 
that recognizes the active GTP-bound forms of Rho A, B, 
and C and is able to discriminate these from the inactive 
GDP-bound form.15
For validating the biomolecular interaction and the specific 
recognition, we used a quartz crystal microbalance (QCM). 
This technology permits the determination of an additional 
mass per unit area by measuring the frequency shift of the 
mechanical resonance of a quartz crystal. That is, when there is 
adsorption of (bio)molecules onto the surface of a piezoelectric 
quartz, decrements in its resonance frequency are registered 
this relationship being governed by the Sauerbrey equation. 
Hence, this technique enables the quantification of deposited 
masses at the surface of the quartz crystal and the characteriza-
tion of the viscoelastic properties of thin adsorbed films. QCM 
technology is particularly well adapted for the development 
and validation of biofunctionalized surfaces or current protein 
chips applications.16 The resolution in frequency has been 
reported to be in the range of 0.2 Hz (in liquid), corresponding 
to a mass resolution of few ng/cm2.17
Thanks to an innovative surface chemistry based on PEG-
Silane and Ni nanoislands deposited onto the thin layer of an 
SiO2-quartz crystal, we were able to selectively detect an active 
form of this potential biomarker using QCM technology. The 
full chemical and biological protocol validated by this experi-
ment can be reproduced on any integrated nanobiosensor such 
as micro/nanocantilevers,18,19 resonant micromembranes,20 or 
interdigitated nanoelectrode devices.21,22
Specifically, this technique is being transferred to a novel 
type of ultrasensitive nanobiosensor (not presented here) 
based on multiple tunnel junctions (MTJ). These devices 
fabricated on silicon technology (e-beam lithography and 
lift-off) use nickel nanoislands, as used here, deposited 
between interdigitated nanoelectrodes and on a silicon 
oxidized substrate, which allow high sensitivities to be 
demonstrated. This is why we used SiO2 quartz surfaces 
decorated with very small Ni nanoislands in this study. 
Hence, the present publication validates the adsorption 
of the probe molecules (conformation specific antibody 
anti-RhoA) on the Ni nanoislands through His linkage, the 
efficiency of the antibiofouling layer around the islands, 
and the capability of our antibodies to detect specific 
conformational modifications of RhoA cancer biomarkers 
in a label-free manner. Finally, it is important to note that we 
used the QCM technology to validate the surface chemistry 
on a surface, as similar as possible as the surface of our MTJ 
devices that we are constructing, to demonstrate and report, 
in future work, high sensitivities.
Material and methods
The measurements were performed using a QCM (Q-sense 
E4, Sweden). The quartz had 50 nm SiO2 on the surface International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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(Q-sense, Sweden) and was then covered with 1 µm 
silicon oxide (SiO2) using plasma-enhanced chemical 
vapor deposition (PECVD), in our clean room facility. For 
control experiments, we used a fluorescence microscope 
(Olympus IX70).
Antibiofouling coating
For many application purposes, related to micro and nano-
biosensors, silicon oxide surfaces are used due to their com-
patibility with silicon technology. We have thus optimized 
a chemical protocol on this type of surface. For this reason 
we have employed quartz crystals covered with a silicon 
oxide thin layer. During the experiments, we immediately 
noticed that the biomolecules of interest for our work (anti-
body fragments and proteins) exhibited some unwanted 
interactions with those SiO2 surfaces. We therefore tested 
several passivation methods to avoid these non-specific 
adsorptions. We decided to use 2[methoxy(polyethyleneoxy)
propyl]trimethoxy silane (Gelest), (Mw 460–590), a silane 
conjugated polyethylene-glycol chain (PEG-silane) because 
of its biocompatibility, and its covalent binding to SiO2. This 
kind of PEG has already been used in nanostructured PEG-
films preparations for silicon-based BioMEMS.23 Briefly, 
PEG-silane molecules and concentrated hydrogen chloride 
(HCl) were mixed in toluene in a clean glass beaker with 
100 µL PEG-silane, 40 µL HCl, and 50 mL of toluene. The 
beaker was then placed in a sonicator for 1 minute and the 
contents were then transferred to another clean glass bea-
ker. A 1.5 cm-diameter piece of quartz, covered with 1 µm 
SiO2-thick (PECVD-deposited layer) was immersed for 
2 hours and washed sequentially with toluene, ethanol, and 
finally deionized water (each step taking 2 minutes). This 
protocol generates an ultrathin PEG layer on the surface 
with a thickness of between 1 nm and 2 nm.24 The quartz 
surface after this functionalization process is schematized 
in Figure 1.
Nickel nanoislands deposition
Different techniques exist for depositing nanoislands, 
including sputtering or vacuum evaporation. The sput-
tering method was disregarded because we did not want 
the deposition process to damage the PEG coating, which 
the sputtering method would have caused due to its ionic 
  bombardment energy.
We used a Veeco 770 thermal evaporator to evaporate a 
1 nm thick Ni film onto the PEG-silane surfaces, at a pressure 
of ∼10−6 mbars at room temperature (RT). For this very low 
thickness, the Ni film is not continuous and spontaneously 
adopts a 3D growth mechanism leading to the formation of 
nanoscale metallic islands. This morphology was confirmed 
by high-resolution scanning electron microscopy (SEM) 
(Hitachi S-4800). A typical image of the deposited film is 
shown in Figure 2.
The Ni nano islands appear as tiny bright spots and a 
statistical analysis of the observed nanoislands indicated 
they had an average diameter of 5 nm. The characterization 
of the thin Ni film was confirmed by atomic force microscopy 
(AFM). Images were obtained in air and in contact mode, 
of a JPK system (NanoWizard® II; JPK Instruments, Berlin, 
Germany) with a force evaluated to 200 pN. A typical image 
is shown in Figure 3.
Using AFM imagery the nanoislands appear larger com-
pared to SEM due to tip convolution effects which tend to 
render hard material objects larger than they are. However, 
the height analysis provided by AFM indicates an average 
vertical dimension (close to 5 nm) in very good agreement 
with the lateral dimension extracted from high magnification 
SEM. Both images (SEM and AFM) indicate that there are 
nanometric gaps between the Ni nanoislands and that their 
coalescence was very limited. In our process, these Ni nano-
islands attach to the antibody fragments through Ni-histidine 
binding. We expect this kind of morphology to be vaulable 
for minimizing the possible denaturation of adsorbed biomol-
ecules on the surface. The final surface of the quartz crystals 
used for the QCM experiments is depicted in Figure 4.
PEG-silane
SiO2
Quartz
Figure 1 schematic representation of a quartz functionalized with an anti-fouling 
Peg-silane coating.
Figure 2 High-resolution SEM image of a granular Ni film (1 nm nominal thickness) 
deposited by thermal evaporation onto a siO2 surface.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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Biomolecule purification
The production and purification of soluble single-chain 
antibodies was performed as follows: TG1 Escherichia 
coli strain harboring the pHEN F7N1N2 plasmid was 
grown in 100 mL of LB medium containing ampicillin 
(100 µg/mL) and 2% of   glucose at 37°C. At a proper con-
centration (OD600 = 0.6 – 0.8), the culture was centrifuged 
at 3.3 × g for 10 min. Bacteria were once more suspended 
in LB medium containing ampicillin (100 µg/mL) and 
incubated in a 0.1 mM IPTG overnight at 30°C. Bacteria 
were harvested and resuspended in 50 mM NaH2PO4, pH 
7.5, 300 mM NaCl, 10 mM imidazole (1/10 of the culture 
volume). The bacteria were then sonicated for 30 min. The 
cell lysate was centrifuged at 17.5 × g for 15 min. The super-
natant containing the scFvs were concentrated on 1 mL of 
50% slurry Ni-NTA agarose (Qiagen, Valencia, CA) at 4°C 
by shaking for at least two hours. After washing with 50 mM 
NaH2PO4, pH 7.5, 300 mM NaCl, 10 mM imidazole, bound 
scFvs were eluted by 50 mM NAH2PO4 pH 7.5, 300 mM 
NaCl, 250 mM imidazole.
Recombinant GST fusion RhoA protein was expressed 
and purified from a protease deficient strain (E. coli BL21). 
Bacteria were grown at 37°C in 1 liter of LB medium 
  containing ampicillin (100 µg/mL) until an OD600 = 0.6 – 0.8 
was reached. Protein expression was induced for overnight 
incubation in 0.1 mM isopropyl-β-D-glactopyranoside 
(IPTG) at 20°C, and cells were harvested. Bacteria pellets 
were frozen at −20°C for 15–20 minutes, and subsequently 
resuspended at 4°C in 50 mM Tris-HCl, pH 7.5, 150 mM 
NaCl, 5 mM MgCl2, and triton × 100 0.1% at 1:10 of the 
original culture volume. Cells were incubated in ice for 
30 minutes then sonicated for five rounds of 15 seconds. 
Lysate was centrifuged at 12.500 × g for 30 min. at 4°C. 
The GST-RhoA containing supernatant was purified using 
the Magnet GSTTM protein purification system (Promega, 
Madison, WI) according to the manufacturer’s instructions.
All purified recombinant proteins were applied to 
PD-10 desalting columns (GE Healthcare, Piscataway, NJ) 
equilibrated with HEPES 10 mM pH 7.5, 150 mM NaCl, 
5 mM MgCl2 to remove glutathione and imidazole.
Samples were analyzed using SDS-PAGE and Coomassie 
blue staining and then stored at 4°C for short term storage 
or −70°C with 15% glycerin for long term storage. Finally, 
for the Rho GTP loading, recombinant GST-RhoA purified 
using glutathione beads, was loaded with 0.1 mM of GDP 
or GTPgS in Hepes 10 mM, 150 mM NaCl, 5 mM MgCl2 
at 37°C for 1 hour.
eLIsA tests
HisGrabTM nickel coated 96-well plates (Pierce, Rockford, 
IL) were incubated for 1 hour at RT with 100 µL of purified 
scFv F7N1N2 (6 µg/mL) in phosphate-buffered saline 
(PBS). The wells were washed three times with PBS Tween 
0.05%, and 100 µl of purified GST-RhoA loaded with GDP 
or GTPgS, was added at appropriate concentrations in PBS, 
5 mM MgCl2. After 1 hour of incubation at RT, the wells 
were washed three times and incubated using anti-GST-HRP 
conjugate (GE Healthcare, RPN1236). The immunoreac-
tion was developed using 3, 3’, 5,5’-tetramethylbenzidine 
(34022; Pierce), stopped by adding 1M sulfuric acid, and 
results were measured using an ELISA reader (Multiskan 
Labsystems, Hopkinton, MA) at OD = 450 nm.
Results and Discussion
To validate the surface chemistry involved for preventing 
non-specific adsorption, we used 0.5 µM of 6His-tagged 
green fluorescent proteins (GFP), onto different quartz 
surfaces (quartz-SiO2, PEG-silane treated quartz-SiO2, 
before and after nanoislands deposition). After incubation 
of the GFP, the surfaces were analyzed by fluorescence 
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Figure 3 AFM image of a granular Ni film (1 nm nominal thickness) deposited by 
thermal evaporation onto a siO2 surface.
Nanoislands (~5 nm)
PEG-Silane (~2 nm)
SiO2
Quartz
Figure 4 schematic representation of a quartz functionalized with an antibiofouling 
Peg-silane coating plus 5 nm size Ni nanoislands.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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microscopy. Figure 5A corroborates that the PEG based 
coating acts as an efficient antibiofouling layer preventing 
the adsorption of proteins. Conversely, on the virgin SiO2 
film (without any surface chemistry treatment), the adsorp-
tion is considerable (Figure 5B). It is also clear that the 
presence of Ni nanoislands changes the repartition of 
the GFP proteins on the surface compared to SiO2 surfaces 
(Figure 5C). It is not possible to obtain any molecular scale 
information by using simple fluorescence characterizations 
but the role of the different layers is clearly identified. The 
PEG-silane coating forms an efficient antibiofouling layer 
between the Ni   nanoislands while the latter induce a robust 
linkage to the surface on specific sites.
All these observations were verified using QCM analysis 
and no noticeable trace of adsorption (no frequency shift) was 
observed in the case of a SiO2 quartz coated with PEG-silane, 
while reproducible frequency shifts were recorded with 
virgin SiO2 quartz and SiO2 quartz treated with PEG-silane 
plus Ni nanoislands.
The first attempts to detect the specific interaction of 
RhoA proteins with probe molecules selective to their active 
form by QCM using quartz crystals treated with PEG and Ni 
nanoislands failed. During these experiments, we identified 
an unexpected adsorption of glycerin (glycerol) on both 
SiO2 surfaces and PEG coated surfaces. We thus concluded 
that minimizing the quantity of glycerine, normally used 
as a cryogenic protectant for proteins storage, was manda-
tory for our experiments. This so-called “glycerin-effect”, 
not noticed in traditional ELISA tests, was found to mask 
completely the specific protein interaction we wanted to 
investigate by QCM. We thus determined the maximum 
glycerin percentage compatible with a convenient storage 
of the proteins and reliable QCM signals. As shown in 
Figure 6, the incubation of a solution containing a ratio of 
0.2% (in volume) of glycerin in HEPES buffer does not 
induce any significant frequency shift on quartz-SiO2 coated 
with PEG and generates only a small variation of 1 Hz 
on virgin SiO2 quartz. Conversely, higher glycerin levels 
(1% or 10%) were found to induce significant unspecific 
adsorption events on both types of surfaces.
When there was a percentage of glycerin higher than 
0.2% mixed with the biomolecules of interest, the QCM 
signals exhibited a response comparable to those obtained 
for pure glycerine. To avoid this bias, the glycerin content 
in our solutions was kept below this level.
In the biomarker detection experiments we used His-
tagged antibody, single chain variable fragments (scFv-
F7N1N2) as a probe molecule, that bind selectively to the 
active antigen conformation RhoA, referred to RhoA-GTPgS 
with respect to the inactive antigen conformation of RhoA, 
then referred to RhoA-GDP.15 To verify the ability of this puri-
fied scFv to bind to nickel atoms while keeping its specificity 
for the active form of RhoA and before the final QCM tests, 
an ELISA test was conducted as follows: Ni-NTA microplates 
were coated with scFv F7N1N2. Specific   interactions were 
ABC
Figure  5  Fluorescence  microscopy  characterizations  of  the  6his-tagged  green 
fluorescent  proteins  (GFP)  adsorption,  onto  the  different  quartz  surfaces. 
A) PEG-silane onto SiO2 B) SiO2 C) PEG-silane plus Ni nanoislands.
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Figure 6 QcM signals obtained after the incubation of a solution of glycerin diluted 
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measured by adding serial dilutions of GST-RhoA loaded 
with GDP or with GTPgS. The amount of GST-RhoA linked 
to the scFv was measured after adding an anti-GST-HRP 
conjugate. Figure 7 contains the results of these ELISA 
experiments, demonstrating the selectivity of our probe 
molecule to the active form of RhoA proteins and the good 
discrimination with respect to the inactive conformation of 
the same protein.
QCM experiments were finally performed at a flow rate 
of 60 mL/min on quartz-SiO2 coated with PEG-silane and 
equipped with Ni nanoislands (similar to the scheme of 
Figure 4). Firstly, Hepes buffer 10 mM, NaCl 150 mM plus 
5 mM of MgCl2 was injected into two similar independent 
quartz sensors, in a parallel manner. Quartz 1 was used to 
detect the active form of RhoA (RhoA GTPgS) and quartz 
2 to detect the inactive form of RhoA (RhoA GDP). The 
results are depicted in Figure 8. At step 1, a 40 µg/mL 
(730 nM) solution of scFv-F7N1N2 was injected into both 
fluidic channels. A frequency variation of around 70 Hz was 
observed in both quartz types, revealing the adsorption of 
the probe molecules on the surface covered with Ni islands. 
HEPES buffer was then injected for removing loosely 
bound molecules and for stabilizing the QCM signal. At 
step 2, a solution of RhoA GTPgS at 4 µg/mL (90 nM) 
was injected into quartz 1 and a solution of RhoA GDP at 
4 µg/mL (90 nM) into quartz 2. As can be seen in Figure 8, 
the curve of the quartz 1 presents a frequency variation shift 
of around 5 Hz which can demonstrate a selective detec-
tion of the active form of RhoA (RhoA GTPgS), relating 
to the inactive form of RhoA (RhoA GDP) in which there 
is no noticeable frequency shift variation. However, we 
wanted to be convinced of this selectivity so we decided 
to increase the surface density of probe molecules grafted 
on the Ni nanoislands by injecting and incubating, at step 
3, a 200 µg/mL (3.6 µM) solution of (scFv)-F7N1N2 into 
both fluidic channels. Hence, an additional frequency shift 
of ∼25 Hz was observed in both reaction chambers (quartz 
1 and quartz 2), which confirms that the surface was not 
initially saturated with probe molecules. At step 4, we 
injected the same concentration of RhoA proteins as at step 
2, that is, 4 µg/mL (90 nM) of active and inactive antigens 
respectively, into quartz 1 and quartz 2. A slight frequency 
shift was observed but could be distinctly attributed to 
a significant stable adsorption on the surface. We then 
increased the concentration of antigens up to 20 µg/mL 
(445 nM) (in step 5) and 40 µg/mL (900 nM) (in step 6) 
of active and inactive antigens respectively, into quartz 1 
and quartz 2. In these cases, a clear adsorption signal was 
recorded in quartz 1 (7 Hz at step 5 and 10 Hz at step 6) 
while no trace of a clear adsorption could be noticed on 
quartz 2. The clear difference between the response of 
quartz 1 and quartz 2, indicates that the label-free detec-
tion of RhoA proteins in their active conformation can be 
achieved by QCM analysis. This result turned out to be 
possible only on quartz crystals equipped with nanometric 
size Ni nanoislands and was reproducibly obtained with 
the same batch of proteins.
Conclusion
We implemented a surface chemistry involving an 
antibiofouling coating of PEG-silane (,2 nm thick) onto 
a SiO2 thin film combined with a deposition of 5 nm size 
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Ni islands. This specific surface chemistry performed onto 
SiO2 surfaces and the nanoscale roughness developed by 
the nanoislands turned out to be suitable for attaching probe 
molecules (antibody fragments) to the Ni islands through a 
Histidine tag, permitting label-free detection of the active 
conformation protein RhoA biomarkers and discriminating 
the inactive conformation. We found that glycerin, often 
used as a cryogenic protectant in molecular biology pro-
tocols, produced non-specific biomolecular interactions. 
A new protocol without glycerin has thus been developed 
and validated by ELISA technique. This work supports 
the viability of the concept of using Ni nanoislands as an 
anchoring surface layer enabling the detection of a specific 
conformation of a protein identified as a potential cancer 
biomarker.
Our aim was not to propose the QCM technology as a 
competitor to ELISA method, indeed the limit of detection, 
as shown in this paper, is poorer with QCM. Hence, QCM 
was used as a method for validating a specific surface 
chemistry on SiO2 surfaces that will be employed on a new 
type of label-free nanobiosensors based on MTJ-based 
nanodevices. This is expected to exhibit high sensitivity 
comparable to ELISA or nanowire-based FET sensors.25 
These MTJ fabricated by silicon technology (e-beam lithog-
raphy) use Ni nanoislands deposited between interdigitated 
nanoelectrodes on a silicon oxidized substrate, as the pro-
tocol validated here. We have demonstrated (results not 
yet published) that when a molecular complex is formed 
onto the Ni nanoislands, the room temperature electrical 
conductivity of these devices, dominated by so-called 
“coulomb blockade effect” change dramatically. This huge 
effect renders possible the label-free integrated and electri-
cal detection of proteins in solution. The present publication 
was therefore a validation of the surface chemistry involved 
in these new kinds of devices. Hence, our results validate 
the adsorption of the probe molecules (conformation-
specific antibody anti RhoA) on the Ni islands through His 
linkage, the efficiency of the antibiofouling layer around 
the islands, and the capability of our antibodies to detect 
specific conformational modifications of RhoA cancer 
biomarkers.
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